Stay updated on Ibrutinib Combo in Recurrent HNSCC Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.

Latest updates to the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page
- Check2 days agoChange DetectedRevision badge updated from v3.6.3 to v3.6.4, indicating a site version update. No study details, eligibility criteria, or results are changed by this update.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a minor update to the listing. This change does not alter the trial details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer release of the page. No changes to the study details or content are introduced.SummaryDifference0.1%

- Check44 days agoChange DetectedRecruitment has ended on this study page ('No longer looking for participants'), and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) to improve navigation. The Intervention/Treatment header formatting was adjusted, the old 'Intervention / Treatment' header removed, and the revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check51 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor page or CMS update. This change does not modify the study details, enrollment information, or outcomes.SummaryDifference0.1%

- Check66 days agoChange DetectedThe study record now shows termination and posted results, with details on efficacy by RECIST v1.1 and linked documentation (PDF of the study protocol and statistical analysis plan) to support the results.SummaryDifference3%

Stay in the know with updates to Ibrutinib Combo in Recurrent HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.